Antibiotic resistance

Large-scale monitoring programmes reveal striking resistance frequencies in both clinical and environmental reservoirs. In the European Union’s 2018/2019 report, resistance among zoonotic bacteria such as Salmonella and Campylobacter was documented across poultry, pork, and cattle production chains, exposing substantial gaps in food-borne surveillance 1. In China’s intensive swine operations, Zhu and colleagues (2013) identified 149 distinct resistance genes, with the top 63 enriched up to 28,000-fold relative to antibiotic-free controls, underscoring the massive selective pressure exerted by livestock antibiotic use 2. Similarly, Pruden and colleagues (2006) demonstrated that dairy lagoon water harboured the highest normalized concentrations of tetracycline and sulfonamide resistance genes, significantly surpassing those in irrigation ditches and river sediments (p < 0.0001) 3.

The genetic mechanisms that enable bacteria to acquire and disseminate resistance are dominated by mobile genetic elements. Partridge and colleagues (2018) detail how plasmids, integrative conjugative elements, and transposons shuttle resistance cassettes across Gram-positive and Gram-negative species, fueling the rapid spread of multidrug-resistant phenotypes within the ESKAPE group 4. Biofilm formation further entrenches resistance, as Høiby and colleagues (2010) describe how the extracellular matrix creates nutrient and oxygen gradients that render embedded cells metabolically dormant and less susceptible to antibiotics 5. Acinetobacter baumannii exemplifies this convergence of mechanisms, with Kyriakidis and colleagues (2021) cataloguing a suite of beta-lactamase, efflux pump, and target-modifying genes that collectively confer resistance to virtually all major antibiotic classes 6.

The human health toll of AMR is stark: Mancuso and colleagues (2021) estimate that at least 700,000 deaths occur annually due to resistant infections, a figure projected to climb to ten million by 2050 if no decisive action is taken 7. This surge threatens the efficacy of routine medical procedures, from surgeries to chemotherapy, as highlighted by Ahmed and colleagues (2024), who warn that the erosion of antibiotic effectiveness could render many life-saving interventions untenable 8. The economic ramifications are equally severe; Siaba and colleagues (2026) report that the attributable cost of resistant infections ranges from €21,629 to €74,452 per patient episode, with Pseudomonas spp. incurring the highest expenses, underscoring the financial strain on healthcare systems 9.

Resistance imposes substantial burdens on healthcare resources. The prospective audit and feedback trial by Livorsi and colleagues (2026) demonstrated that targeted stewardship at hospital discharge reduced post-discharge antibiotic use, suggesting that unchecked prescribing contributes to unnecessary drug exposure and associated costs 10. In orthopaedic trauma, Schrank and colleagues (2025) found no significant increase in antimicrobial-resistant fracture-related infections despite the use of local antibiotics, indicating that certain prophylactic strategies may not exacerbate resistance while still offering clinical benefit 11. Conversely, the cluster-randomized trial by Wei and colleagues (2026) achieved a 39-percentage-point reduction in antibiotic prescribing for acute respiratory infections, highlighting how stewardship can directly curtail unnecessary antibiotic consumption and its downstream consequences 12.

Agricultural and food sectors are deeply affected by AMR. Zhu and colleagues (2013) identified massive enrichment of ARGs in swine manure, with some genes amplified up to 28,000-fold, reflecting the extensive reservoir of resistance in livestock environments 2. The European Union’s 2018/2019 surveillance report documented high rates of ESBL-producing Escherichia coli and methicillin-resistant Staphylococcus aureus in poultry and pork products, indicating that food-borne pathways serve as vectors for resistant bacteria to reach consumers 1. In Tanzania, a systematic review by Kafaiya and colleagues (2026) found that 25% of clinical isolates originated from urine samples and exhibited notable resistance to commonly used antibiotics, emphasizing the regional impact of AMR on treatment outcomes and public health 13.

Beyond human health, AMR threatens ecosystems and the efficacy of environmental services. Zafar and colleagues (2026) highlighted that hospital, municipal, and industrial wastewaters in Iran harbor high prevalences of clinically significant resistant organisms, including MRSA (22%) and ESBL-producing E. coli (up to 80% in slaughterhouse effluents), illustrating how wastewater streams act as conduits for resistance dissemination 14. Microplastic-associated biofilms further concentrate mobile ARGs, as shown by Zarean and colleagues (2026), which may facilitate the spread of high-risk resistance determinants across freshwater habitats 15. These findings underscore the interconnectedness of human, animal, and environmental reservoirs in sustaining the global AMR crisis.

The overuse and misuse of antibiotics in human medicine, animal husbandry, and agriculture generate intense selective pressure that drives the emergence of resistance, a theme emphasized by Davies and Davies (2010) and further elaborated by Munita and Arias (2016) 1617. Under this pressure, bacterial populations evolve through spontaneous mutations, acquisition of resistance-conferring genes, and altered expression of existing pathways, enabling survival against drug exposure. The review by Aslam and colleagues (2018) highlights that such selective forces are compounded by regulatory and financial barriers that limit the development of new antimicrobial agents, creating a feedback loop that perpetuates resistance proliferation 18.

Horizontal gene transfer (HGT) serves as the principal conduit for disseminating resistance across microbial communities. Zhu and colleagues (2013) reported a strong correlation (r² = 0.96) between the abundance of transposase genes and ARGs in Chinese swine manure, implicating transposon-mediated HGT as a driver of ARG enrichment 2. Partridge and colleagues (2018) similarly describe how plasmids, integrons, and gene cassettes facilitate inter-species exchange of resistance determinants, especially among the ESKAPE pathogens, thereby accelerating the spread of multidrug-resistant traits 4. The environmental dimension of HGT is further illustrated by Pruden and colleagues (2006), who observed that heavy metals present in agricultural runoff co-select for ARGs, enhancing the mobility of resistance genes in soil and water ecosystems 3.

Biofilm formation creates a protected niche where bacteria exhibit heightened tolerance to antimicrobials. Høiby and colleagues (2010) explain that gradients of nutrients and oxygen within biofilms lead to reduced metabolic activity and prolonged doubling times, rendering cells less vulnerable to antibiotic action 5. Pang and colleagues (2018) expand on this by noting that Pseudomonas aeruginosa employs both intrinsic mechanisms, such as efflux pumps, and adaptive strategies, including persister cell formation, to survive antibiotic exposure within biofilms 19. Sharma and colleagues (2023) further emphasize that the extracellular polymeric matrix impedes drug penetration and facilitates quorum-sensing-regulated resistance, making conventional antibiotic regimens largely ineffective against biofilm-associated infections 20.

Co-selection by non-antibiotic agents amplifies resistance evolution. Pruden and colleagues (2006) demonstrated that dairy lagoon waters contain elevated concentrations of both antibiotics and heavy metals, suggesting that metal exposure can select for ARGs even in the absence of direct antibiotic pressure 3. Zhu and colleagues (2013) corroborated this by linking the enrichment of transposase genes to the presence of heavy metals in swine manure, indicating that metal-driven HGT may accelerate ARG dissemination 2. Moreover, Aslam and colleagues (2018) argue that the combined impact of agricultural runoff, wastewater discharge, and clinical antibiotic misuse creates a synergistic environment that fuels the persistence and spread of resistance across ecological boundaries 18.

Mass azithromycin distribution (MDA) has produced divergent findings regarding its impact on resistance. Doan and colleagues (2026) reported that semi-annual azithromycin MDA increased gut macrolide resistance by a fold change of 1.16 compared with placebo, yet nasopharyngeal resistance did not rise significantly, suggesting tissue-specific effects 21. In contrast, Kalizang'oma and colleagues (2025) observed a persistent elevation of Streptococcus pneumoniae macrolide resistance three and a half years after a similar MDA programme, indicating long-term community-level resistance amplification despite the cessation of treatment 22. These opposing outcomes highlight uncertainty about the durability and scope of resistance following MDA interventions.

The efficacy of pharmacist-led audit-feedback within antimicrobial stewardship programs is another area of disagreement. Jawhar and colleagues (2026) synthesized data from fourteen randomized and quasi-experimental studies and concluded that pharmacist-driven audit-feedback yielded a modest but statistically significant reduction in inappropriate antibiotic use, with pooled effect sizes reflecting modest improvements 23. Conversely, the stepped-wedge cluster-randomized trial by Wei and colleagues (2026) demonstrated a dramatic 39-percentage-point drop in antibiotic prescribing for acute respiratory infections after implementing a digitally enabled stewardship package, suggesting that more intensive, technology-augmented interventions may achieve far greater impact than audit-feedback alone 12. The disparity may stem from differences in intervention relative attention, setting, and baseline prescribing behaviours.

Hospital-based antibiotic stewardship programs have become a cornerstone of resistance mitigation. Barlam and colleagues (2016) outlined evidence-based guidelines that integrate multidisciplinary expertise to optimise antibiotic use across inpatient settings, emphasizing core strategies such as prospective audit and feedback, formulary restriction, and education 24. The prospective audit and feedback trial by Livorsi and colleagues (2026) applied these principles at discharge, achieving a measurable reduction in post-discharge antibiotic prescriptions, thereby confirming the real-world effectiveness of stewardship interventions when rigorously implemented 10. Complementary digital tools, as evaluated by Wei and colleagues (2026), further amplified these gains by embedding evidence-based prompts within electronic medical records, resulting in a 39-percentage-point decrease in prescribing for acute respiratory infections 12.

Mass drug administration of azithromycin has been explored as a public-health strategy to lower child mortality, yet its resistance implications are mixed. The AVENIR trial by Doan and colleagues (2026) demonstrated that semi-annual azithromycin MDA reduced mortality among children but concurrently increased gut macrolide resistance (fold change 1.16), raising concerns about long-term ecological impacts 21. Kalizang'oma and colleagues (2025) later reported that, three and a half years after a similar MDA programme, macrolide-resistant Streptococcus pneumoniae remained elevated in the community, suggesting that resistance effects may persist well beyond the intervention period 22. These findings underscore the need to balance immediate health benefits against potential resistance amplification.

Novel therapeutic avenues are being pursued to circumvent traditional antibiotic resistance. Muteeb and colleagues (2023) discuss emerging strategies such as phage therapy, CRISPR-Cas9-based gene editing, and the development of natural-product-derived compounds, all of which aim to target resistant pathogens with precision while sparing commensal flora 25. Pang and colleagues (2018) specifically highlight alternative approaches for Pseudomonas aeruginosa, including anti-biofilm agents, quorum-sensing inhibitors, and immunotherapeutic vaccines, many of which are currently in pre-clinical evaluation but show promise for future clinical translation 19. Sharma and colleagues (2023) also review innovative technologies such as nanocarriers and photodynamic therapy that could disrupt biofilm integrity and restore antibiotic susceptibility, indicating a growing pipeline of adjunctive treatments 20.

Rapid diagnostic technologies are reshaping stewardship by enabling timely, pathogen-directed therapy. The INHALE trial by Enne and colleagues (2025) compared standard care with syndromic PCR-guided antibiotic selection in intensive-care patients with hospital-acquired pneumonia, finding that 76.5% of the PCR arm received appropriate, proportionate antibiotics within 24 hours, albeit without a clear superiority in clinical cure 26. Similarly, the prospective audit and feedback study by Livorsi and colleagues (2026) leveraged electronic health record reviews to assess prescribing appropriateness at discharge, demonstrating that targeted feedback can improve prescribing quality without compromising patient outcomes 10. Together, these studies illustrate how rapid molecular testing, when coupled with stewardship oversight, can enhance antimicrobial use while mitigating resistance development.

Zhang and colleagues (2021) introduced an omics-based framework that stratifies antibiotic resistance genes by human-association, mobility, and pathogenicity, identifying a subset of high-risk ARGs that constitute only 3.6% of all detected genes but account for the majority of current clinical threats 27. Applying this framework to gut microbiome datasets revealed that while 73% of genomes harboured some ARGs, only 8.9% contained high-risk variants, offering a nuanced risk-assessment tool that can prioritize surveillance efforts and inform targeted interventions.

Artificial intelligence is emerging as a powerful ally in AMR combat. Ahmed and colleagues (2024) discuss how machine-learning algorithms are being trained on large-scale genomic and phenotypic datasets to predict resistance patterns, accelerate diagnostic turnaround, and suggest optimal therapeutic regimens, albeit with challenges related to data quality and algorithmic bias 8. Early implementations of AI-driven decision support in stewardship programs have shown promise in reducing inappropriate prescribing, suggesting a future where predictive analytics could preemptively curb resistance emergence.

Microplastics as vectors for resistance genes represent a newly recognized frontier. Zarean and colleagues (2026) performed a meta-analysis revealing that plastic-associated biofilms preferentially enrich high-risk ARG categories, including β-lactamase and macrolide resistance genes, relative to surrounding water, thereby creating novel niches for resistance proliferation 15. This insight prompts interdisciplinary research into mitigation strategies, such as biodegradable polymers and targeted biofilm disruption, to limit the environmental spread of clinically relevant resistance determinants.